{"id":29517,"date":"2024-07-01T08:13:38","date_gmt":"2024-07-01T07:13:38","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=29517"},"modified":"2024-07-01T08:13:38","modified_gmt":"2024-07-01T07:13:38","slug":"les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/","title":{"rendered":"Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques"},"content":{"rendered":"\n<p>Depuis la pand\u00e9mie de COVID-19, les tests de diagnostic tels que la PCR et les tests rapides font d\u00e9sormais partie du lexique public. Le diagnostic rapide \u00e0 \u00e9galement un r\u00f4le crucial pour identifier et traiter les infections microbiennes, et pour ralentir la r\u00e9sistance aux antimicrobiens (RAM ou AMR en anglais).<\/p>\n\n\n\n<p>L\u2019\u00e9volution rapide des savoirs m\u00e9dicaux, biologiques, technologiques et num\u00e9riques incite l\u2019industrie du diagnostic in vitro \u00e0 investir plus que jamais dans le d\u00e9veloppement de solutions innovantes. De nouveaux tests diagnostiques sont mis au service des laboratoires et des plateaux techniques pour soutenir une meilleure prescription antimicrobienne tout au long du parcours de soins.<\/p>\n\n\n\n<p>Ceci se traduit&nbsp;:<\/p>\n\n\n\n<ul>\n<li>En m\u00e9decine de ville, avec des tests r\u00e9alis\u00e9s en pr\u00e9sence et \u00e0 proximit\u00e9 du patient lors de la consultation chez le m\u00e9decin (Point of Care Testing POCT). Par exemple, dans le cas des infections respiratoires, l\u2019identification rapide et simplifi\u00e9e des pathog\u00e8nes est possible \u00e0 l\u2019aide de panels syndromiques, ou de tests rapides, ou de tests r\u00e9alis\u00e9s sur des plateaux techniques centralis\u00e9s des laboratoires biologiques\u00a0; \u00a0\u00a0<\/li>\n\n\n\n<li>\u00c0 l\u2019h\u00f4pital, avec des tests d\u00e9localis\u00e9s dans les services d\u2019urgences \u00e0 proximit\u00e9 des patients (Near Patient Testing NPT), et au niveau du laboratoire central o\u00f9 l\u2019on peut r\u00e9aliser des panels syndromiques, des tests d\u2019identification microbiologique, et des antibiogrammes. Ces laboratoires b\u00e9n\u00e9ficient de fa\u00e7on croissante de logiciels d\u2019agr\u00e9gation de l\u2019information (Clinical Decision Support Systems CDSS), qui facilitent l\u2019analyse des r\u00e9sultats.<\/li>\n<\/ul>\n\n\n\n<p>Quel que soit le lieu de r\u00e9alisation des tests de diagnostic, la digitalisation des r\u00e9sultats joue un r\u00f4le primordial pour assurer la tra\u00e7abilit\u00e9 et le lien avec le dossier du patient et son parcours de soin. Le but est d\u2019offrir plus de rapidit\u00e9, de pr\u00e9cision, au meilleur co\u00fbt et au plus pr\u00e8s des patients et des professionnels de sant\u00e9, sans compromis aucun sur la qualit\u00e9 de l\u2019offre diagnostique.<\/p>\n\n\n\n<p>Les nouveaux tests diagnostiques, utilis\u00e9s de fa\u00e7on adapt\u00e9e par les \u00e9quipes soignantes et pluridisciplinaires (<em>e.g.<\/em> comit\u00e9 de bon usage des antibiotiques, hygi\u00e9nistes), contribuent \u00e0 une meilleure utilisation des antibiotiques&nbsp;; \u00e0 diminuer le risque d\u2019antibior\u00e9sistance&nbsp;; \u00e0 une meilleure qualit\u00e9 des soins (<em>e.g.<\/em> infections respiratoires aig\u00fces<sup>1<\/sup>, bact\u00e9ri\u00e9mies <sup>2, 3<\/sup>, utilisation de CDSS<sup>4<\/sup>)&nbsp;; et \u00e0 une plus grande efficience des \u00e9tablissements de sant\u00e9. Un diagnostic rapide et pointu permet d\u2019\u00e9viter ou de diminuer les actes m\u00e9dicaux inutiles et les tests plus longs et on\u00e9reux devenus obsol\u00e8tes, tout en d\u00e9gageant du temps m\u00e9dical et favorisant l\u2019autonomie du personnel soignant (<em>e.g.<\/em> NPT aux urgences<sup>5<\/sup>). Au-del\u00e0, c\u2019est toute la gestion des infections communautaires et acquises \u00e0 l\u2019h\u00f4pital qui b\u00e9n\u00e9ficie de cette innovation diagnostique.<\/p>\n\n\n\n<p>Les b\u00e9n\u00e9fices d\u2019un parcours de soin am\u00e9lior\u00e9 s\u2019\u00e9tendent au niveau soci\u00e9tal quand le patient sort de l\u2019h\u00f4pital&nbsp;: moins de r\u00e9admissions, capacit\u00e9 \u00e0 retravailler ou retourner rapidement \u00e0 l\u2019\u00e9cole, moins de s\u00e9quelles \u00e0 court et long-terme. Ce sont ces impacts soci\u00e9taux qu\u2019il convient de valoriser \u00e0 leur juste mesure.<\/p>\n\n\n\n<p>Dans un contexte de contraintes budg\u00e9taires et organisationnelles exacerb\u00e9es pour les syst\u00e8mes de sant\u00e9, il y a des opportunit\u00e9s d\u2019efficience en termes de valeur m\u00e9dico-\u00e9conomique qui peuvent \u00eatre exploit\u00e9es. Il convient d\u2019\u00e9valuer l\u2019impact des \u00e9volutions diagnostiques r\u00e9centes dans toutes leurs dimensions, en ville comme \u00e0 l\u2019h\u00f4pital, pour le patient, pour les professionnels de sant\u00e9, et pour la soci\u00e9t\u00e9.<\/p>\n\n\n\n<p>C\u2019est pourquoi le comit\u00e9 strat\u00e9gique de fili\u00e8re sant\u00e9 \u00ab&nbsp;antibior\u00e9sistance&nbsp;\u00bb a d\u00e9cid\u00e9 d\u2019en faire un axe de travail collaboratif en y associant&nbsp;: les autorit\u00e9s gouvernementales, les organismes de recherche acad\u00e9miques, des \u00e9conomistes de la sant\u00e9, et les industriels pharmaceutiques et du diagnostic in vitro.<\/p>\n\n\n\n<p>Quel meilleur engagement pour le bien commun ?<\/p>\n\n\n\n<div style=\"height:17px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:16px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\">R\u00e9f\u00e9rences<\/h3>\n\n\n\n<p><sup>1<\/sup>Subramony 2016. Impact of Multiplex Polymerase Chain Reaction Testing for Respiratory Pathogens on Healthcare Resource Utilization for Pediatric Inpatients. J Pediatr http:\/\/dx.doi.org\/10.1016\/j.jpeds.2016.02.050<\/p>\n\n\n\n<p><sup>1<\/sup> Subramony 2016. Impact of Multiplex Polymerase Chain Reaction Testing for Respiratory Pathogens on Healthcare Resource Utilization for Pediatric Inpatients. J Pediatr http:\/\/dx.doi.org\/10.1016\/j.jpeds.2016.02.050<\/p>\n\n\n\n<p><sup>2<\/sup> Timbrook, 2017. The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis. Clin. Infec. Dis. 64(1):15-23<\/p>\n\n\n\n<p><sup>3<\/sup> Pliakos 2018. The Cost-Effectiveness of Rapid Diagnostic Testing for the Diagnosis of Bloodstream Infections with or without Antimicrobial Stewardship Clin. Microbiol. Rev. 2018:31(3):E00095-17<\/p>\n\n\n\n<p><sup>4  <\/sup>Laka 2020. Can Evidence-Based Decision Support Tools Transform Antibiotic Management? A Systematic Review and Meta-Analyses. J. Antimicrobial. Chem. 75(5):1099-1111<\/p>\n\n\n\n<p><sup>5 <\/sup> Clark 2020. Clinical impact of a routine, molecular, point-of-care, testand-treat strategy for influenza in adults admitted tohospital (FluPOC): a multicentre, open-label, randomized controlled trial. Lancet Respir Med; 9: 419\u201329<\/p>\n\n\n\n<div style=\"height:9px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:10px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Auteur<\/h3>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile\"><figure class=\"wp-block-media-text__media\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"720\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-1024x720.jpg\" alt=\"\" class=\"wp-image-29518 size-full\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-1024x720.jpg 1024w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-300x211.jpg 300w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-768x540.jpg 768w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-1536x1079.jpg 1536w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-2048x1439.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p><strong>Fran\u00e7ois Lacoste<\/strong><\/p>\n\n\n\n<p><em>Senior VP Public Health<\/em><\/p>\n\n\n\n<p><a href=\"https:\/\/www.institut-merieux.com\/fr\/\">Institut Merieux<\/a><\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Depuis la pand\u00e9mie de COVID-19, les tests de diagnostic tels que la PCR et les tests rapides font d\u00e9sormais partie du lexique public. Le diagnostic rapide \u00e0 \u00e9galement un r\u00f4le crucial pour identifier et traiter les infections microbiennes, et pour ralentir la r\u00e9sistance aux antimicrobiens (RAM ou AMR en anglais). L\u2019\u00e9volution rapide des savoirs m\u00e9dicaux, [&hellip;]<\/p>\n","protected":false},"author":271,"featured_media":29518,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[3341],"tags":[6607,6673,6691,6581,6689],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-01T07:13:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1799\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Loane Serrano\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Loane Serrano\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/\"},\"author\":{\"name\":\"Loane Serrano\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61\"},\"headline\":\"Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques\",\"datePublished\":\"2024-07-01T07:13:38+00:00\",\"dateModified\":\"2024-07-01T07:13:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/\"},\"wordCount\":831,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-scaled.jpg\",\"keywords\":[\"Antibior\u00e9sistance\",\"Edito\",\"Partenariat public priv\u00e9\",\"resistance\",\"test diagnostique\"],\"articleSection\":[\"Editoriaux\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/\",\"name\":\"Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-scaled.jpg\",\"datePublished\":\"2024-07-01T07:13:38+00:00\",\"dateModified\":\"2024-07-01T07:13:38+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-scaled.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-scaled.jpg\",\"width\":2560,\"height\":1799},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Editoriaux\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61\",\"name\":\"Loane Serrano\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/","og_locale":"fr_FR","og_type":"article","og_title":"Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2024-07-01T07:13:38+00:00","og_image":[{"width":2560,"height":1799,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-scaled.jpg","type":"image\/jpeg"}],"author":"Loane Serrano","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Loane Serrano","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/"},"author":{"name":"Loane Serrano","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61"},"headline":"Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques","datePublished":"2024-07-01T07:13:38+00:00","dateModified":"2024-07-01T07:13:38+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/"},"wordCount":831,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-scaled.jpg","keywords":["Antibior\u00e9sistance","Edito","Partenariat public priv\u00e9","resistance","test diagnostique"],"articleSection":["Editoriaux"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/","name":"Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-scaled.jpg","datePublished":"2024-07-01T07:13:38+00:00","dateModified":"2024-07-01T07:13:38+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-scaled.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2024\/06\/QLA09748-1-scaled.jpg","width":2560,"height":1799},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/les-tests-diagnostiques-un-atout-pour-le-bon-usage-des-antibiotiques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Editoriaux","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/"},{"@type":"ListItem","position":3,"name":"Les tests diagnostiques \u2013 un atout pour le bon usage des antibiotiques"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61","name":"Loane Serrano"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-14 09:21:11","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/29517"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/271"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=29517"}],"version-history":[{"count":11,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/29517\/revisions"}],"predecessor-version":[{"id":30132,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/29517\/revisions\/30132"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/29518"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=29517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=29517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=29517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}